KWM
BIIB icon

Kingsview Wealth Management’s Biogen BIIB Stock Holding History

Kingsview Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$212K Buy
+1,156
New +$213K ﹤0.01% 1228
2023
Q3 		– Sell
-1,101
Closed -$314K – 935
2023
Q2 		$314K Buy
+1,101
New +$328K 0.01% 727
2017
Q4 		– Sell
-762
Closed -$239K – 398
2017
Q3 		$239K Buy
+762
New +$226K 0.11% 239

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Kingsview Wealth Management's BIIB Position: Q1 2026 in Review

Kingsview Wealth Management opened a new position in Biogen (BIIB) in Q1 2026: 1,156 shares worth $212K. The stake represents ﹤0.01% of the portfolio and ranks #1228 among its holdings. This is a return to the name: Kingsview Wealth Management previously reported a position in BIIB as recently as Q2 2023.

Kingsview Wealth Management first reported a position in BIIB in Q3 2017 and has held it in 3 quarters since. The position peaked at $314K in Q2 2023. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Kingsview Wealth Management held 1,156 shares of Biogen worth $212K as of Q1 2026.
  • Biogen was a new Kingsview Wealth Management position in Q1 2026.
  • Biogen made up ﹤0.01% of Kingsview Wealth Management's portfolio in Q1 2026, its #1228 holding.
  • Kingsview Wealth Management first reported a position in Biogen in Q3 2017 and has held it in 3 quarters since.
  • Kingsview Wealth Management's Biogen position peaked at $314K in Q2 2023.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Kingsview Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.